Software Suppliers Supporting the Pharmaceuticals Value Chain

Price: Starting at USD 4,500
Publish Date: 21 Dec 2022
Code: PT-2532
Research Type: Presentation
Software Suppliers Supporting the Pharmaceuticals Value Chain
Actionable Benefits

Actionable Benefits

  • Understand the reasons why companies operating in the pharmaceutical value chain need to upgrade their software.
  • Identify suppliers that are looking to support firms’ drug discovery, clinical trials, and manufacturing activities.
  • Evaluate suppliers’ approaches to serving customer needs.
Critical Questions Answered

Critical Questions Answered

  • What are the key focus areas for software suppliers when engaging with different parts of the pharmaceutical value chain?
  • What drives and inhibits investments in software solutions.
  • The main tenants of vendors’ solutions and ABI Research’s thoughts on how well they meet market requirements.
Research Highlights

Research Highlights

  • Concise backdrop to how software supports pharmaceutical firms’ efforts to bring drugs to market sooner, while remaining regulatory compliant.
  • Profiles of 12 vendors looking to improve the lives of practitioners in laboratories, those running clinical trials, and those tasked with producing the drugs, medicines, and vaccines.
  • An “ABI Research Verdict” on each vendor’s solution.
Who Should Read This?

Who Should Read This?

  • Decision makers responsible for optimizing processes at pharmaceutical firms and their partners.
  • System integrators who need to understand the potential role for software solutions at their client sites.
  • Vendor marketing leads looking to understand how competitors are positioning their capabilities.
  • Decision makers and strategists within: Device Original Equipment Manufacturers (OEMs) Software platform vendors Investment banks
  • Device Original Equipment Manufacturers (OEMs) Software platform vendors Investment banks
  • Device Original Equipment Manufacturers (OEMs)
  • Software platform vendors
  • Investment banks

Table of Contents

Introduction

Factors Affecting the Pharmaceutical Value Chain and the Use of Software

Innovators Supporting the Drug Discovery and Preclinical Stages 

Innovators Supporting Clinical Trial Programs 

Innovators Supporting Pharma Manufacturing Operations